Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3

V. Liakina; S. Hamid; J. Tanaka; S. Olafsson; A. I. Sharara; S. M. Alavian; L. Gheorghe; E. S. El Hassan; F. Abaalkhail; Z. Abbas; A. Abdou; A. Abourached; F. Al Braiki; F. Al Hosani; K. Al Jaberi; M. Al Khatry; M. A. Al Mulla; H. Al Quraishi; A. Al Rifai; Y. Al Serkal; A. Alam; H. I. Alashgar; S. Alawadhi; L. Al-Dabal; P. Aldins; F. Z. Alfaleh; A. S. Alghamdi; R. Al-Hakeem; A. A. Aljumah; A. Almessabi; A. N. Alqutub; K. A. Alswat; I. Altraif; M. Alzaabi; N. Andrea; A. M. Assiri; M. A. Babatin; A. Baqir; M. T. Barakat; O. M. Bergmann; A. R. Bizri; S. Blach; A. Chaudhry; M. S. Choi; T. Diab; S. Djauzi; S. El Khoury; C. Estes; S. Fakhry; J. I. Farooqi; H. Fridjonsdottir; R. A. Gani; A. Ghafoor Khan; A. Goldis; M. Gottfredsson; S. Gregorcic; B. Hajarizadeh; K. H. Han; I. Hasan; A. Hashim; G. Horvath; B. Hunyady; R. Husni; W. Jafri; A. Jeruma; J. G. Jonasson; B. Karlsdottir; D. Y. Kim; Y. S. Kim; Z. Koutoubi; L. A. Lesmana; Y. S. Lim; A. Löve; M. Maimets; M. Makara; R. Malekzadeh; M. Matičič; M. S. Memon; S. Merat; J. E. Mokhbat; F. H. Mourad; D. H. Muljono; A. Nawaz; N. Nugrahini; S. Priohutomo; H. Qureshi; P. Rassam; H. Razavi; D. Razavi-Shearer; K. Razavi-Shearer; B. Rozentale; M. Sadik; K. Saeed; A. Salamat; R. Salupere; F. M. Sanai; A. Sanityoso Sulaiman; R. A. Sayegh; J. D. Schmelzer; A. Sibley; M. Siddiq; A. M. Siddiqui; G. Sigmundsdottir; B. Sigurdardottir; D. Speiciene; A. Sulaiman; M. A. Sultan; M. Taha; H. Tarifi; G. Tayyab; I. Tolmane; M. Ud Din; M. Umar; J. Valantinas; J. Videčnik-Zorman; C. Yaghi; E. Yunihastuti; M. A. Yusuf; B. F. Zuberi; J. Gunter

doi:10.1111/jvh.12475

Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3

V. Liakina
, S. Hamid
, J. Tanaka
, S. Olafsson
, A. I. Sharara
, S. M. Alavian
, L. Gheorghe
, E. S. El Hassan
, F. Abaalkhail
, Z. Abbas
, A. Abdou
, A. Abourached
, F. Al Braiki
, F. Al Hosani
, K. Al Jaberi
, M. Al Khatry
, M. A. Al Mulla
, H. Al Quraishi
, A. Al Rifai
, Y. Al Serkal

A. Alam, H. I. Alashgar, S. Alawadhi, L. Al-Dabal, P. Aldins, F. Z. Alfaleh, A. S. Alghamdi, R. Al-Hakeem, A. A. Aljumah, A. Almessabi, A. N. Alqutub, K. A. Alswat, I. Altraif, M. Alzaabi, N. Andrea, A. M. Assiri, M. A. Babatin, A. Baqir, M. T. Barakat, O. M. Bergmann, A. R. Bizri, S. Blach, A. Chaudhry, M. S. Choi, T. Diab, S. Djauzi, S. El Khoury, C. Estes, S. Fakhry, J. I. Farooqi, H. Fridjonsdottir, R. A. Gani, A. Ghafoor Khan, A. Goldis, M. Gottfredsson, S. Gregorcic, B. Hajarizadeh, K. H. Han, I. Hasan, A. Hashim, G. Horvath, B. Hunyady, R. Husni, W. Jafri, A. Jeruma, J. G. Jonasson, B. Karlsdottir, D. Y. Kim, Y. S. Kim, Z. Koutoubi, L. A. Lesmana, Y. S. Lim, A. Löve, M. Maimets, M. Makara, R. Malekzadeh, M. Matičič, M. S. Memon, S. Merat, J. E. Mokhbat, F. H. Mourad, D. H. Muljono, A. Nawaz, N. Nugrahini, S. Priohutomo, H. Qureshi, P. Rassam, H. Razavi, D. Razavi-Shearer, K. Razavi-Shearer, B. Rozentale, M. Sadik, K. Saeed, A. Salamat, R. Salupere, F. M. Sanai, A. Sanityoso Sulaiman, R. A. Sayegh, J. D. Schmelzer, A. Sibley, M. Siddiq, A. M. Siddiqui, G. Sigmundsdottir, B. Sigurdardottir, D. Speiciene, A. Sulaiman, M. A. Sultan, M. Taha, H. Tarifi, G. Tayyab, I. Tolmane, M. Ud Din, M. Umar, J. Valantinas, J. Videčnik-Zorman, C. Yaghi, E. Yunihastuti, M. A. Yusuf, B. F. Zuberi, J. Gunter

Department of Internal Medicine

Vilnius University
Vilnius Gediminas Technical University
Aga Khan University
Hiroshima University
Landspitali University Hospital
American University of Beirut
Tehran University of Medical Sciences
Middle East Liver Diseases Centre
Fundeni Clinical Institute
Dubai Health Authority
Alfaisal University
Ziauddin University
Ministry of Public Health Lebanon
Abu Dhabi Health Services Company
Health Authority Abu Dhabi
Ras Al Khaimah Hospital
Al Marfaq Hospital
Ministry of Health, United Arab Emirates
Shaikh Zayed Hospital
King Faisal Specialist Hospital and Research Centre
Riga East University Hospital
King Saud University
King Fahad Medical City
Ministry of Health, Saudi Arabia
King Abdulaziz Medical City - Riyadh
Zayed Military Hospital
Daman National Health Insurance Company
Seyal Medical Centre
Center for Disease Analysis
Siddiq Sadiq Hospital
University of Indonesia
University of Balamand
Abu Dhabi Police
Khyber Medical University
Lady Reading Hospital
Victor Babes University of Medicine and Pharmacy
University Medical Centre Ljubljana
University of New South Wales
La Trobe University
Yonsei University
Hepatology Center of Buda
Mor Teaching Hospital
University of Pecs
Lebanese American University
Infectology Center of Latvia
Riga Stradins University
Icelandic Cancer Society
Soonchunhyang University
Cleveland Clinic Abu Dhabi
Medistra Hospital
University of Ulsan
Tartu University Hospital
St. István and St. László Hospital
Asian Institute of Medical Science (AIMS)
Eijkman Institute for Molecular Biology
The University of Sydney
Fatima Memorial Hospital
Ministry of Health, Indonesia
Pakistan Institute of Development Economics
Khawar Clinic
Military Hospital
Saint Joseph University
Allama Iqbal Medical College
Yusra Medical College
Centre for Health Security and Communicable Disease Control
Klinik Hati Prof. Ali Sulaiman
Enaya Insurance Company
Lahore General Hospital
Doctors Hospital and Medical Center
Pakistan Society of Gastroenterology
Rawalpindi Medical College
Holy Family Hospital, Rawalpindi
Shaukat Khanum Memorial Cancer Hospital and Research Centre
Dow University of Health Sciences

Research output: Contribution to journal › Article › peer-review

80 Scopus citations

Abstract

Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.

Original language	English
Pages (from-to)	4-20
Number of pages	17
Journal	Journal of Viral Hepatitis
Volume	22
DOIs	https://doi.org/10.1111/jvh.12475
State	Published - Dec 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

diagnosis
disease burden
epidemiology
hepatitis C
hepatitis C virus
historical
incidence
mortality
prevalence
treatment

Access to Document

10.1111/jvh.12475

Cite this

Liakina, V., Hamid, S., Tanaka, J., Olafsson, S., Sharara, A. I., Alavian, S. M., Gheorghe, L., El Hassan, E. S., Abaalkhail, F., Abbas, Z., Abdou, A., Abourached, A., Al Braiki, F., Al Hosani, F., Al Jaberi, K., Al Khatry, M., Al Mulla, M. A., Al Quraishi, H., Al Rifai, A., ... Gunter, J. (2015). Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3. Journal of Viral Hepatitis, 22, 4-20. https://doi.org/10.1111/jvh.12475

@article{5e5fbced350e4adbaf6cf52959a8e826,

title = "Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3",

abstract = "Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2\% in Iran and Lebanon to 4.2\% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.",

keywords = "diagnosis, disease burden, epidemiology, hepatitis C, hepatitis C virus, historical, incidence, mortality, prevalence, treatment",

author = "V. Liakina and S. Hamid and J. Tanaka and S. Olafsson and Sharara, \{A. I.\} and Alavian, \{S. M.\} and L. Gheorghe and \{El Hassan\}, \{E. S.\} and F. Abaalkhail and Z. Abbas and A. Abdou and A. Abourached and \{Al Braiki\}, F. and \{Al Hosani\}, F. and \{Al Jaberi\}, K. and \{Al Khatry\}, M. and \{Al Mulla\}, \{M. A.\} and \{Al Quraishi\}, H. and \{Al Rifai\}, A. and \{Al Serkal\}, Y. and A. Alam and Alashgar, \{H. I.\} and S. Alawadhi and L. Al-Dabal and P. Aldins and Alfaleh, \{F. Z.\} and Alghamdi, \{A. S.\} and R. Al-Hakeem and Aljumah, \{A. A.\} and A. Almessabi and Alqutub, \{A. N.\} and Alswat, \{K. A.\} and I. Altraif and M. Alzaabi and N. Andrea and Assiri, \{A. M.\} and Babatin, \{M. A.\} and A. Baqir and Barakat, \{M. T.\} and Bergmann, \{O. M.\} and Bizri, \{A. R.\} and S. Blach and A. Chaudhry and Choi, \{M. S.\} and T. Diab and S. Djauzi and \{El Khoury\}, S. and C. Estes and S. Fakhry and Farooqi, \{J. I.\} and H. Fridjonsdottir and Gani, \{R. A.\} and \{Ghafoor Khan\}, A. and A. Goldis and M. Gottfredsson and S. Gregorcic and B. Hajarizadeh and Han, \{K. H.\} and I. Hasan and A. Hashim and G. Horvath and B. Hunyady and R. Husni and W. Jafri and A. Jeruma and Jonasson, \{J. G.\} and B. Karlsdottir and Kim, \{D. Y.\} and Kim, \{Y. S.\} and Z. Koutoubi and Lesmana, \{L. A.\} and Lim, \{Y. S.\} and A. L{\"o}ve and M. Maimets and M. Makara and R. Malekzadeh and M. Mati{\v c}i{\v c} and Memon, \{M. S.\} and S. Merat and Mokhbat, \{J. E.\} and Mourad, \{F. H.\} and Muljono, \{D. H.\} and A. Nawaz and N. Nugrahini and S. Priohutomo and H. Qureshi and P. Rassam and H. Razavi and D. Razavi-Shearer and K. Razavi-Shearer and B. Rozentale and M. Sadik and K. Saeed and A. Salamat and R. Salupere and Sanai, \{F. M.\} and \{Sanityoso Sulaiman\}, A. and Sayegh, \{R. A.\} and Schmelzer, \{J. D.\} and A. Sibley and M. Siddiq and Siddiqui, \{A. M.\} and G. Sigmundsdottir and B. Sigurdardottir and D. Speiciene and A. Sulaiman and Sultan, \{M. A.\} and M. Taha and H. Tarifi and G. Tayyab and I. Tolmane and \{Ud Din\}, M. and M. Umar and J. Valantinas and J. Vide{\v c}nik-Zorman and C. Yaghi and E. Yunihastuti and Yusuf, \{M. A.\} and Zuberi, \{B. F.\} and J. Gunter",

note = "Publisher Copyright: {\textcopyright} 2015 John Wiley \& Sons Ltd.",

year = "2015",

month = dec,

doi = "10.1111/jvh.12475",

language = "English",

volume = "22",

pages = "4--20",

journal = "Journal of Viral Hepatitis",

issn = "1352-0504",

publisher = "Wiley-Blackwell Publishing Ltd",

}

Liakina, V, Hamid, S, Tanaka, J, Olafsson, S, Sharara, AI, Alavian, SM, Gheorghe, L, El Hassan, ES, Abaalkhail, F, Abbas, Z, Abdou, A, Abourached, A, Al Braiki, F, Al Hosani, F, Al Jaberi, K, Al Khatry, M, Al Mulla, MA, Al Quraishi, H, Al Rifai, A, Al Serkal, Y, Alam, A, Alashgar, HI, Alawadhi, S, Al-Dabal, L, Aldins, P, Alfaleh, FZ, Alghamdi, AS, Al-Hakeem, R, Aljumah, AA, Almessabi, A, Alqutub, AN, Alswat, KA, Altraif, I, Alzaabi, M, Andrea, N, Assiri, AM, Babatin, MA, Baqir, A, Barakat, MT, Bergmann, OM, Bizri, AR, Blach, S, Chaudhry, A, Choi, MS, Diab, T, Djauzi, S, El Khoury, S, Estes, C, Fakhry, S, Farooqi, JI, Fridjonsdottir, H, Gani, RA, Ghafoor Khan, A, Goldis, A, Gottfredsson, M, Gregorcic, S, Hajarizadeh, B, Han, KH, Hasan, I, Hashim, A, Horvath, G, Hunyady, B, Husni, R, Jafri, W, Jeruma, A, Jonasson, JG, Karlsdottir, B, Kim, DY, Kim, YS, Koutoubi, Z, Lesmana, LA, Lim, YS, Löve, A, Maimets, M, Makara, M, Malekzadeh, R, Matičič, M, Memon, MS, Merat, S, Mokhbat, JE, Mourad, FH, Muljono, DH, Nawaz, A, Nugrahini, N, Priohutomo, S, Qureshi, H, Rassam, P, Razavi, H, Razavi-Shearer, D, Razavi-Shearer, K, Rozentale, B, Sadik, M, Saeed, K, Salamat, A, Salupere, R, Sanai, FM, Sanityoso Sulaiman, A, Sayegh, RA, Schmelzer, JD, Sibley, A, Siddiq, M, Siddiqui, AM, Sigmundsdottir, G, Sigurdardottir, B, Speiciene, D, Sulaiman, A, Sultan, MA, Taha, M, Tarifi, H, Tayyab, G, Tolmane, I, Ud Din, M, Umar, M, Valantinas, J, Videčnik-Zorman, J, Yaghi, C, Yunihastuti, E, Yusuf, MA, Zuberi, BF & Gunter, J 2015, 'Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3', Journal of Viral Hepatitis, vol. 22, pp. 4-20. https://doi.org/10.1111/jvh.12475

TY - JOUR

T1 - Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3

AU - Liakina, V.

AU - Hamid, S.

AU - Tanaka, J.

AU - Olafsson, S.

AU - Sharara, A. I.

AU - Alavian, S. M.

AU - Gheorghe, L.

AU - El Hassan, E. S.

AU - Abaalkhail, F.

AU - Abbas, Z.

AU - Abdou, A.

AU - Abourached, A.

AU - Al Braiki, F.

AU - Al Hosani, F.

AU - Al Jaberi, K.

AU - Al Khatry, M.

AU - Al Mulla, M. A.

AU - Al Quraishi, H.

AU - Al Rifai, A.

AU - Al Serkal, Y.

AU - Alam, A.

AU - Alashgar, H. I.

AU - Alawadhi, S.

AU - Al-Dabal, L.

AU - Aldins, P.

AU - Alfaleh, F. Z.

AU - Alghamdi, A. S.

AU - Al-Hakeem, R.

AU - Aljumah, A. A.

AU - Almessabi, A.

AU - Alqutub, A. N.

AU - Alswat, K. A.

AU - Altraif, I.

AU - Alzaabi, M.

AU - Andrea, N.

AU - Assiri, A. M.

AU - Babatin, M. A.

AU - Baqir, A.

AU - Barakat, M. T.

AU - Bergmann, O. M.

AU - Bizri, A. R.

AU - Blach, S.

AU - Chaudhry, A.

AU - Choi, M. S.

AU - Diab, T.

AU - Djauzi, S.

AU - El Khoury, S.

AU - Estes, C.

AU - Fakhry, S.

AU - Farooqi, J. I.

AU - Fridjonsdottir, H.

AU - Gani, R. A.

AU - Ghafoor Khan, A.

AU - Goldis, A.

AU - Gottfredsson, M.

AU - Gregorcic, S.

AU - Hajarizadeh, B.

AU - Han, K. H.

AU - Hasan, I.

AU - Hashim, A.

AU - Horvath, G.

AU - Hunyady, B.

AU - Husni, R.

AU - Jafri, W.

AU - Jeruma, A.

AU - Jonasson, J. G.

AU - Karlsdottir, B.

AU - Kim, D. Y.

AU - Kim, Y. S.

AU - Koutoubi, Z.

AU - Lesmana, L. A.

AU - Lim, Y. S.

AU - Löve, A.

AU - Maimets, M.

AU - Makara, M.

AU - Malekzadeh, R.

AU - Matičič, M.

AU - Memon, M. S.

AU - Merat, S.

AU - Mokhbat, J. E.

AU - Mourad, F. H.

AU - Muljono, D. H.

AU - Nawaz, A.

AU - Nugrahini, N.

AU - Priohutomo, S.

AU - Qureshi, H.

AU - Rassam, P.

AU - Razavi, H.

AU - Razavi-Shearer, D.

AU - Razavi-Shearer, K.

AU - Rozentale, B.

AU - Sadik, M.

AU - Saeed, K.

AU - Salamat, A.

AU - Salupere, R.

AU - Sanai, F. M.

AU - Sanityoso Sulaiman, A.

AU - Sayegh, R. A.

AU - Schmelzer, J. D.

AU - Sibley, A.

AU - Siddiq, M.

AU - Siddiqui, A. M.

AU - Sigmundsdottir, G.

AU - Sigurdardottir, B.

AU - Speiciene, D.

AU - Sulaiman, A.

AU - Sultan, M. A.

AU - Taha, M.

AU - Tarifi, H.

AU - Tayyab, G.

AU - Tolmane, I.

AU - Ud Din, M.

AU - Umar, M.

AU - Valantinas, J.

AU - Videčnik-Zorman, J.

AU - Yaghi, C.

AU - Yunihastuti, E.

AU - Yusuf, M. A.

AU - Zuberi, B. F.

AU - Gunter, J.

PY - 2015/12

Y1 - 2015/12

N2 - Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.

AB - Detailed, country-specific epidemiological data are needed to characterize the burden of chronic hepatitis C virus (HCV) infection around the world. With new treatment options available, policy makers and public health officials must reconsider national strategies for infection control. In this study of 15 countries, published and unpublished data on HCV prevalence, viraemia, genotype, age and gender distribution, liver transplants and diagnosis and treatment rates were gathered from the literature and validated by expert consensus in each country. Viraemic prevalence in this study ranged from 0.2% in Iran and Lebanon to 4.2% in Pakistan. The largest viraemic populations were in Pakistan (7 001 000 cases) and Indonesia (3 187 000 cases). Injection drug use (IDU) and a historically unsafe blood supply were major risk factors in most countries. Diagnosis, treatment and liver transplant rates varied widely between countries. However, comparison across countries was difficult as the number of cases changes over time. Access to reliable data on measures such as these is critical for the development of future strategies to manage the disease burden.

KW - diagnosis

KW - disease burden

KW - epidemiology

KW - hepatitis C

KW - hepatitis C virus

KW - historical

KW - incidence

KW - mortality

KW - prevalence

KW - treatment

UR - https://www.scopus.com/pages/publications/84945351461

U2 - 10.1111/jvh.12475

DO - 10.1111/jvh.12475

M3 - Article

C2 - 26513445

AN - SCOPUS:84945351461

SN - 1352-0504

VL - 22

SP - 4

EP - 20

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

ER -

Historical epidemiology of hepatitis C virus (HCV) in select countries - Volume 3

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this